Instituto Nacional de Enfermedades Neoplásicas
In research, Instituto Nacional de Enfermedades Neoplásicas stands highest in Health Sciences (#8,286 of 11,982 worldwide) and Medicine (#8,423 of 10,443 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology — Oncology is 10.9× its share of world research.
- World rank, 2022–2025
- #18,158 of 28,054 · #25,594 all time
- Rank in Peru
- #44 of 100
- Research works
- 948 ▲ 34% vs 2013–17
- Citations
- 8k 8.4 per fractional work
- Top-10% rate
- 4.7% record average 16.5%
- Open access
- 57% world 28%
What is Instituto Nacional de Enfermedades Neoplásicas known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Health SciencesDomain | #8,286 of 11,982 | 4.2% | 175 | #11930 | |
| MedicineField | #8,423 of 10,443 | 4.2% | 161 | #9963 |
Each strip is that field’s whole ranked pool, with the notch where Instituto Nacional de Enfermedades Neoplásicas sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Instituto Nacional de Enfermedades Neoplásicas specialise in?
Where its research is concentrated relative to its size: Oncology takes 10.9× the share of its output that it takes of world research.
- OncologySubfield · 27.0 works11×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.8×. Every wedge is a field page.
- Medicine 3.8×
- Immunology and Microbiology 2.1×
- Health Professions 2.1×
- Biochemistry, Genetics and Molecular Biology 1.6×
- Veterinary 1.2×
- Nursing 0.8×
- Psychology 0.7×
- Dentistry 0.6×
- Economics, Econometrics and Finance 0.6×
- Neuroscience 0.6×
- Physics and Astronomy 0.3×
- Environmental Science 0.2×
- Social Sciences 0.1×
- Business, Management and Accounting 0.1×
- Agricultural and Biological Sciences 0.1×
- Computer Science 0.1×
- Engineering 0.0×
Who are the top researchers at Instituto Nacional de Enfermedades Neoplásicas?
Ranked on the composite score, Henry Gómez, Victor Castro Oliden and Carlos Vallejos lead among researchers whose main affiliation is Instituto Nacional de Enfermedades Neoplásicas.
- 1 Henry Gómez Peru · #90,785 worldwide 416 citations · 96 works
- 2 Victor Castro Oliden Peru · #403,721 worldwide 103 citations · 15 works
- 3 Carlos Vallejos Peru · #513,424 worldwide 92 citations · 37 works
- 4 Sandro Casavilca‐Zambrano Peru · #659,556 worldwide 49 citations · 27 works
- 5 Carlos A. Castañeda Peru · #787,054 worldwide 49 citations · 28 works
- 6 Miluska Castillo Peru · #788,530 worldwide 47 citations · 17 works
- 7 Mónica Calderón Peru · #890,679 worldwide 9 citations · 17 works
- 8 Eloy Ruíz Peru · #933,056 worldwide 13 citations · 16 works
- 9 Luis Taxa Peru · #1,116,713 worldwide 3 citations · 15 works
- 10 Henry Gómez Peru · #1,262,336 worldwide 19 citations · 15 works
Which keywords describe research at Instituto Nacional de Enfermedades Neoplásicas?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Clinical Practice Guidelines, Prognostic Factors, Immunotherapy, Quality of Life, Survival Analysis, Radiotherapy and Epidemiology.
- Aging Population
- Osteosarcoma
- Immunohistochemistry
- Soft Tissue Sarcoma
- Radiation Therapy
- Health Promotion
- Tumor Microenvironment
- Hodgkin's Lymphoma
- Cervical Cancer
- Rituximab
- Targeted Therapy
- Gene Expression Profiling
- Molecular Profiling
- Neoadjuvant Therapy
- Breast Cancer
- Treatment
- Radiotherapy
- Immunotherapy
- Prognostic Factors
- Epidemiology
- Chemotherapy
- Clinical Practice Guidelines
- Quality of Life
- Survival Analysis
- Clinical Trials
- Public Health
- Diagnosis
- Genetic Mutations
- Metastasis
- Lymphoma
- PET Imaging
- Classification
- Genetic Pathogenesis
- Molecular Classification
- Cancer Incidence
- Genomic Characterization
- Surgical Management
- Ewing's Sarcoma
- Molecular Characterization
- Molecular Subtypes
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy28▲ 18×21 topics
- Epidemiology21▲ 2.4×54 topics
- Clinical Practice Guidelines18▲ 15×9 topics
- Prognostic Factors18▲ 19×14 topics
- Quality of Life16▲ 5.0×23 topics
- Immunotherapy15▲ 9.8×16 topics
- Survival Analysis12▲ 21×6 topics
- Radiotherapy12▲ 14×10 topics
- Clinical Trials11▲ 7.5×9 topics
- Treatment11▲ 4.1×21 topics
- Public Health10▲ 3.1×26 topics
- Breast Cancer10▲ 19×10 topics
- Diagnosis9▲ 4.4×21 topics
- Neoadjuvant Therapy9▲ 17×5 topics
- Genetic Mutations8▲ 8.9×12 topics
- Molecular Profiling8▲ 39×3 topics
- Metastasis8▲ 11×7 topics
- Gene Expression Profiling8▲ 45×2 topics
- Lymphoma8▲ 23×3 topics
- Targeted Therapy8▲ 16×4 topics
- PET Imaging8▲ 21×4 topics
- Rituximab7▲ 22×2 topics
- Classification7▲ 7.0×4 topics
- Cervical Cancer6▲ 28×3 topics
- Genetic Pathogenesis6▲ 54×1 topic
- Hodgkin's Lymphoma6▲ 54×1 topic
- Molecular Classification6▲ 19×4 topics
- Tumor Microenvironment6▲ 6.2×6 topics
- Cancer Incidence6▲ 20×4 topics
- Health Promotion6▲ 8.4×8 topics
- Genomic Characterization5▲ 19×3 topics
- Radiation Therapy5▲ 19×4 topics
- Surgical Management5▲ 5.9×11 topics
- Soft Tissue Sarcoma5▲ 43×2 topics
- Ewing's Sarcoma5▲ 48×1 topic
- Immunohistochemistry5▲ 31×4 topics
- Molecular Characterization5▲ 13×6 topics
- Osteosarcoma5▲ 48×1 topic
- Molecular Subtypes5▲ 27×3 topics
- Aging Population5▲ 24×3 topics
Which research topics does Instituto Nacional de Enfermedades Neoplásicas publish most on?
By volume in 2022–2025: Lymphoma Diagnosis and Treatment, Sarcoma Diagnosis and Treatment, Lung Cancer Treatments and Mutations and Breast Cancer Treatment Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 6 works
- 2 Sarcoma Diagnosis and Treatment Pulmonary and Respiratory Medicine 5 works
- 3 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 4 works
- 4 Breast Cancer Treatment Studies Cancer Research 4 works
- 5 Endometrial and Cervical Cancer Treatments Obstetrics and Gynecology 3 works
- 6 Ovarian cancer diagnosis and treatment Reproductive Medicine 3 works
- 7 Pancreatic and Hepatic Oncology Research Oncology 3 works
- 8 Nursing care and research Pharmacy 2 works
- 9 Glioma Diagnosis and Treatment Genetics 2 works
- 10 Cardiac, Anesthesia and Surgical Outcomes Cardiology and Cardiovascular Medicine 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Instituto Nacional de Enfermedades Neoplásicas's research output changed?
Output in 2018–2022 was 34% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Lima
- National University of San Marcos
- Pontificia Universidad Católica del Perú
- Universidad Peruana Cayetano Heredia
- Peruvian University of Applied Sciences
- Universidad de Lima
- Universidad Nacional Agraria La Molina
- Universidad de San Martín de Porres
- Universidad Científica del Sur
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.